This is consistent with recent studies which have demonstrated that DKK-1 and noggin are expressed in high levels in human clinical samples of breast cancer bone metastases [19,20,48,50], with DKK-1 expression being significantly lower in osteoblastic metastatic lesions and in breast cancer patients with non-bone metastases [20]. Here, NOG is linked to breast cancer.